« Back
Home /
Aflibercept; Recombinant human VEGFRs, Fc tag

Aflibercept; Recombinant human VEGFRs, Fc tag

Item no.	THP-0006-100ug
Manufacturer	Creative BioMart
Amount	100 ug
Quantity options	100 ug 1 mg 200 ug
Category	Oncology By Cell Type Carcinoma Peptides & Proteins Recombinant Proteins Cell Biology Cell Culture Cytokines Adenocarcinoma By Organ Bladder Cancer
Type	Proteins Recombinant
Specific against	Human (Homo sapiens)
Host	CHO cells
Purity	>99% by SDS-Page and HPLC analysis
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Available
Manufacturer - Type	Protein
Manufacturer - Applications	The opthalmic agent is used for the treatment of neovascular (wet) age-related mascular degeneration (AMD) and macular edema following central retinal vein occulsion (CRVO). The systemic injection, known as ziv-aflibercept, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is for the treatment of metastatic colorectal cancer that is resistant to or progressed following treatment with oxaliplatin.
Manufacturer - Category	Therapeutic proteins
Storage Conditions	Store it under sterile conditions at -20 to-70°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Molecular Weight	115KDa (with glycosylation)
Description	Aflibercept; Recombinant human VEGFRs, Fc tag

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 1/29/2026

Express Delivery: Save 1 days

Compare

Add to wishlist

Get an offer